Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]
Linda Elsegood - LDN, MS, The LDN Research Trust and Me (2019 Conference) (LDN, low dose naltrexone)
Linda Elsegood, Trustee of the LDN Research Trust, discusses why LDN isn’t widely prescribed, content on the LDN Research Trust website, The LDN Book, and what’s next for the Trust.
Linda Elsegood's Interview with Romina Melwani 2020
They talked about Low Dose Naltrexone (LDN), Multiple Sclerosis (MS), The LDN Books and the LDN Research Trust.
Linda Elsegood: Today we are joined by Dr. David Bornstein. Thank you for joining us, David.
Dr David Borenstein: Thank you for having me.
Part of the LDN Book 2 Tour with Motivate Medicine and Mark Drugs October 2020
Dr. Sarah Zielsdorf MD, MS - Part 2 The LDN Book 2 Launch with Mark Drugs and Motivated Medicine
Part of the LDN Book 2 Tour with Motivated Medicine and Mark Drugs
Dr. Adam Livingston, PharmD, BSc., RPh.
Low-dose Naltrexone (LDN) Prescription Basics
Dr. Adrienne Junek, MD, CCFP, ABOIM
Low-dose Naltrexone (LDN) & Chronic Pain